TrialBritish journal of clinical pharmacology2014

A phase II, randomized, placebo-controlled, double-blind, multi-dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes.

Arun Baksi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.